PortfoliosLab logoPortfoliosLab logo
IZRL vs. ARKG
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IZRL vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Israel Innovative Technology ETF (IZRL) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IZRL achieves a 4.08% return, which is significantly lower than ARKG's 17.09% return.


IZRL

1D
-2.54%
1M
1.92%
YTD
4.08%
6M
7.41%
1Y
29.75%
3Y*
20.69%
5Y*
0.63%
10Y*

ARKG

1D
-0.24%
1M
10.92%
YTD
17.09%
6M
10.02%
1Y
53.35%
3Y*
0.67%
5Y*
-15.72%
10Y*
7.22%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IZRL vs. ARKG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IZRL
ARK Israel Innovative Technology ETF
4.08%36.94%15.28%11.39%-38.61%-3.55%34.12%21.75%-6.17%1.69%
ARKG
ARK Genomic Revolution Multi-Sector ETF
17.09%23.04%-28.24%16.22%-53.90%-33.92%180.40%44.00%-1.26%0.51%

Correlation

The correlation between IZRL and ARKG is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.52

Correlation (3Y)
Calculated over the trailing 3-year period

0.60

Correlation (5Y)
Calculated over the trailing 5-year period

0.69

Correlation (All Time)
Calculated using the full available price history since Dec 6, 2017

0.68

The correlation between IZRL and ARKG shifts across timeframes, from 0.52 (1 year) to 0.69 (5 years), reflecting how their relationship changes across market environments.

IZRL vs. ARKG - Sectors Allocation Comparison


Sectors
IZRL
ARKG

Technology

49.8%

-

Healthcare

18.8%
99.2%

Communication Services

13.9%

-

Industrials

7.7%

-

Consumer Cyclical

6.8%

-

Consumer Defensive

1.5%

-

Financial Services

1.5%
0.5%

Basic Materials

-

-

Energy

-

-

Real Estate

-

-

Utilities

-

-

Technology

IZRL
49.8%
ARKG

-

Healthcare

IZRL
18.8%
ARKG
99.2%

Communication Services

IZRL
13.9%
ARKG

-

Industrials

IZRL
7.7%
ARKG

-

Consumer Cyclical

IZRL
6.8%
ARKG

-

Consumer Defensive

IZRL
1.5%
ARKG

-

Financial Services

IZRL
1.5%
ARKG
0.5%

Basic Materials

IZRL

-

ARKG

-

Energy

IZRL

-

ARKG

-

Real Estate

IZRL

-

ARKG

-

Utilities

IZRL

-

ARKG

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IZRL vs. ARKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IZRL
IZRL Risk / Return Rank: 3636
Overall Rank
IZRL Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
IZRL Sortino Ratio Rank: 3939
Sortino Ratio Rank
IZRL Omega Ratio Rank: 3535
Omega Ratio Rank
IZRL Calmar Ratio Rank: 3333
Calmar Ratio Rank
IZRL Martin Ratio Rank: 3232
Martin Ratio Rank

ARKG
ARKG Risk / Return Rank: 3535
Overall Rank
ARKG Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3737
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3232
Omega Ratio Rank
ARKG Calmar Ratio Rank: 3838
Calmar Ratio Rank
ARKG Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IZRL vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Israel Innovative Technology ETF (IZRL) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IZRLARKGDifference
Sharpe ratioReturn per unit of total volatility

+0.08

Sortino ratioReturn per unit of downside risk

+0.06

Omega ratioGain probability vs. loss probability

1.24

1.22

+0.01

Calmar ratioReturn relative to maximum drawdown

1.64

1.95

-0.31

Martin ratioReturn relative to average drawdown

4.81

4.67

+0.15

IZRL vs. ARKG - Sharpe Ratio Comparison

The current IZRL Sharpe Ratio is 1.39, which is comparable to the ARKG Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of IZRL and ARKG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IZRLARKGDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.39

1.31

+0.08

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.03

-0.35

+0.37

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.13

+0.12

Drawdowns

IZRL vs. ARKG - Drawdown Comparison

The maximum IZRL drawdown since its inception was -59.98%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for IZRL and ARKG.


Loading charts...

Drawdown Indicators


IZRLARKGDifference

Max Drawdown

Largest peak-to-trough decline

-59.98%

-83.59%

+23.61%

Max Drawdown (1Y)

Largest decline over 1 year

-18.27%

-27.51%

+9.24%

Max Drawdown (3Y)

Largest decline over 3 years

-24.60%

-51.96%

+27.36%

Max Drawdown (5Y)

Largest decline over 5 years

-53.21%

-80.18%

+26.97%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

Current Drawdown

Current decline from peak

-15.42%

-69.65%

+54.23%

Average Drawdown

Average peak-to-trough decline

-25.77%

-35.87%

+10.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.20%

11.46%

-5.26%

Volatility

IZRL vs. ARKG - Volatility Comparison

The current volatility for ARK Israel Innovative Technology ETF (IZRL) is 6.12%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.90%. This indicates that IZRL experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IZRLARKGDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.12%

11.90%

-5.78%

Volatility (6M)

Calculated over the trailing 6-month period

16.26%

28.77%

-12.51%

Volatility (1Y)

Calculated over the trailing 1-year period

21.57%

41.12%

-19.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.27%

45.61%

-21.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.84%

41.12%

-16.28%

IZRL vs. ARKG - Expense Ratio Comparison

IZRL has a 0.49% expense ratio, which is lower than ARKG's 0.75% expense ratio.


Dividends

IZRL vs. ARKG - Dividend Comparison

IZRL's dividend yield for the trailing twelve months is around 2.49%, while ARKG has not paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%
IZRL
ARK Israel Innovative Technology ETF
2.49%2.59%0.45%0.00%0.00%0.34%0.00%2.15%3.08%0.00%

Frequently Asked Questions


IZRL and ARKG have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARKG has higher volatility (11.90%) compared to IZRL (6.12%). In terms of maximum drawdown, IZRL dropped -59.98% vs ARKG's -83.59%.

On 5-year performance, IZRL leads with 0.63% vs -15.72% for ARKG. On fees, IZRL is cheaper at 0.49% per year. On volatility, IZRL has been the lower-risk option at 6.12%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, IZRL has performed better with a 0.63% return vs -15.72%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IZRL is cheaper with a 0.49% expense ratio, compared with 0.75% for ARKG.

IZRL has the higher dividend yield at 2.49%, compared with 0.00% for ARKG.

IZRL is categorized as Technology Equities, while ARKG is Health & Biotech Equities. Their fees differ too: 0.49% for IZRL and 0.75% for ARKG.

IZRL currently has the higher Sharpe Ratio (1.39 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IZRL and ARKG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer